Seminar: The New Patent Law and What it Means to You

Speaker Bio: Michael J. Flibbert

Video Impact of U.S. Patent Reform on Patent Litigation

Michael J. Flibbert is a partner in the law firm of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. He focuses on patent litigation before U.S. district courts and the U.S. Court of Appeals for the Federal Circuit. He has handled cases involving a range of technologies primarily in the areas of pharmaceuticals, biotechnology, chemistry, agriculture, and materials science. Mr. Flibbert has extensive experience in representing pharmaceutical patent holders in Paragraph IV Abbreviated New Drug Application (ANDA) litigations arising under the Hatch-Waxman Act. He has participated in both bench and jury patent trials in federal district courts as well as several appeals before the Federal Circuit.

In his patent litigation practice, Mr. Flibbert has served as lead counsel and participated in all aspects of discovery, trial, post-trial, and appellate proceedings. As litigation counsel, he regularly formulates trial and appellate strategies, performs pre-suit investigations, takes and defends fact and expert depositions, represents clients in claim construction and summary judgment hearings, examines and cross-examines witnesses at trial, and argues pre-trial and posttrial motions. He also counsels clients on a range of intellectual property and litigation matters, including patent infringement, validity, enforceability, appeals, jurisdiction, and remedies. In addition, Mr. Flibbert has experience in antitrust law, licensing, mediation, and settlement proceedings. He holds a J.D. with honors from George Washington University, and a B.S. from Georgetown University.

***

Last Update: 02 November 2011
Contact: IEEE-USA, ieeeusa@ieee.org